Page 2 of 5

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 10:28
by vahini
4. warfarin
ciprofloxacin should not recommended for patients taking warfarin it will lead to increase inr level

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 10:30
by Kamal Rathinam
4. WARFARIN is the drug prescribed on the inpatient chart indicates that the patient has an elevated INR.

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 10:30
by vahini
5. warfarin

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 10:32
by Sherin
8. If it is injected too rapidly or in too high a dose, it may cause cardiac arrest within minutes. The effect of hyperkalaemia on the heart is complex – virtually any arrhythmia may be observed

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 10:39
by Solomon Benny
2.drug interactions :digoxin and warfarin _loss of anticoagulant control .
this is a major pharmaceutical problem

3.patient is dehydrated % also suffering from uti,so she should drink lots of fluids,
digoxin should be taken for only 5 days a week.
avoid chances of bleeding ,
using equipments for urinary tract should be a sterilised one .

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 10:43
by vahini
5.warfarin

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 10:45
by vahini
1.The medication history, documented on the handwritten GP referral letter, included digoxin 0.625 mg daily, warfarin, furosemide 20 mg daily, gliclazide 80 mg twice daily, Tylex two tablets when required for pain, alendronate and Adcal-D3 plus ciprofloxacin 250 mg twice daily. An allergy to penicillin was also noted by the GP.

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 10:45
by Sherin
9.
step 1
Carry out a baseline assessment in a near patient
area (e.g., ward, clinic, home) in which injectables are prepared.

Step 2 – Product Risk Factor Assessment

Carry out a baseline assessment of individual
injectable products stocked and used in a near patient area.
step3:
identify risk reduction measures
step 4:
implement risk reduction strategies

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 10:45
by vahini
1.The medication history, documented on the handwritten GP referral letter, included digoxin 0.625 mg daily, warfarin, furosemide 20 mg daily, gliclazide 80 mg twice daily, Tylex two tablets when required for pain, alendronate and Adcal-D3 plus ciprofloxacin 250 mg twice daily. An allergy to penicillin was also noted by the GP.

Re: Medicine Risk Management - Case Study

Posted: 07 Oct 2017, 10:47
by Solomon Benny
2.drug interactions :digoxin and warfarin _loss of anticoagulant control .
this is a major pharmaceutical problem

3.patient is dehydrated % also suffering from uti,so she should drink lots of fluids,
digoxin should be taken for only 5 days a week.
avoid chances of bleeding ,
using equipments for urinary tract should be a sterilised one .